Rachel Kondo, creator and head writer of the hit series Shogun, has never shied away from confronting life’s most difficult ...

One of the major highlights of the Muscular Dystrophy Association (MDA) Clinical & Scientific Conference is that invaluable networking opportunities can help clinicians elevate their own best ...

Speakers from the Muscular Dystrophy Association (MDA) highlighted 75 years of progress in understanding and treating ...

Researchers focused on Myotonic Dystrophy 1 heart problems are testing a novel approach to restore normal function.

An 8-year-old northern Minnesota boy is one of the first in the country to receive a specific type of gene therapy treatment.

The Family Achievement Center will offer family-oriented physical, occupational and speech therapies once it opens in May.

Regenxbio has reported positive interim data from the Phase I/II portion of its Affinity Duchenne study, which is examining ...

The company behind the drug, Sarepta Therapeutics, said that the patient suffered acute liver injury, a known side effect, ...

Satellos Bioscience Inc. (TSX: MSCL, OTCQB: MSCLF) ("Satellos" or the "Company"), a biotech company developing new small molecule therapeutic approaches to improve the treatment of muscle diseases and ...

UCB, a global biopharmaceutical company, today announced positive data from studies involving its investigational pyrimidine nucleoside therapy, doxecitine (dC) and doxribtimine (dT), in people living ...